28
Participants
Start Date
February 3, 2021
Primary Completion Date
September 29, 2023
Study Completion Date
September 29, 2023
palbociclib plus letrozole
palbociclib plus letrozole
Chiba cancer center, Chiba
National Hospital Organization Shikoku Cancer Center, Matsuyama
Hiroshima City Hiroshima Citizens Hospital, Hiroshima
National Hospital Organization Hokkaido Cancer Center, Sapporo
Kumamoto University Hospital, Kumamoto
Saitama Cancer Center, Kita-adachi-gun
National Cancer Center Hospital, Chuo-ku
National Hospital Organization Kyushu Cancer Center, Fukuoka
Hakuaikai Medical Corporation Sagara Hospital, Kagoshima
Kumamoto Shinto General Hospital, Kumamoto
Kyoto University Hospital, Kyoto
Aichi Cancer Center, Nagoya
National Hospital Organization - Osaka National Hospital - Institute For Clinical Research, Osaka
Lead Sponsor
Pfizer
INDUSTRY